Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts

Journal of Dermatological Science

Volumn 55, Issue 1, 2009, Pages 18-26

  Kideryova L ^a   Lacina, L ^a   Dvorankova B ^a   Stork J ^a   Cada Z ^a   Szabo, P ^a   Andre S ^b   Kaltner, H ^b   Gabius, H J ^b   Smetana Jr , K ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Benign fibrous histiocytoma; Fibroblasts; Galectin; Keratin; Nucleostemin

Indexed keywords

BIOLOGICAL MARKER; CELL ANTIBODY; CYTOKERATIN 19; GALECTIN 1; KI 67 ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; DERMATOFIBROMA; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALIGNANT FIBROUS HISTIOCYTOMA; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

BIOLOGICAL MARKERS; CELLS, CULTURED; COCULTURE TECHNIQUES; EPIDERMIS; FIBROBLASTS; GALECTIN 1; HISTIOCYTOMA, BENIGN FIBROUS; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; KERATIN-19; KERATINOCYTES; SKIN NEOPLASMS;

EID: 65649136895     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.03.009     Document Type: Article

References (49)

1. Hügel H. Fibrohistiocytic skin tumors. J Dtsch Dermatol Ges 4 (2006) 544-555
2. Rahbari H., and Mehregan A.H. Adnexal displacement and regression in association with histiocytoma. J Cutaneous Pathol 12 (1985) 94-102
3. Biberstein H. Fibrome mit atypischer Epithelwucherung. Arch Dermatol Syphilol 164 (1931) 69-81
4. Halpryn H.J., and Allen A.C. Epidermal changes associated with sclerosing hemangiomas. Arch Dermatol 80 (1959) 160-166
5. Schoenfeld R.J. Epidermal proliferations overlying histiocytomas. Arch Dermatol 90 (1964) 266-270
6. Dalziel K., and Marks R. Hair follicle-like changes over histiocytomas. Am J Dermatopathol 8 (1986) 462-466
7. Cheng L., Amini S.B., and Zaim M.T. Follicular basal cell hyperplasia overlying dermatofibroma. Am J Surg Pathol 21 (1997) 711-718
8. Han K.-H., Huh C.-H., and Cho K.-H. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma. Immunohistochemical characterization. Am J Dermatopathol 23 (2001) 90-98
9. Folpe A.L., and Cooper K. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors. Arch Pathol Lab Med 131 (2007) 1517-1524
10. Blanpain C., and Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22 (2006) 339-373
11. Watt F.M., and Hogan B.L. Out of Eden: stem cells and their niches. Science 287 (2000) 1427-1430
12. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., et al. Defining the epithelial stem cell niche in skin. Science 303 (2004) 359-363
13. Chang H.Y., Chi J.T., Dudoit S., Bondre C., van de Rijn M., Botstein D., et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. PNAS 99 (2002) 12877-12882
14. Yamaguchi Y., Itami S., Tarutani M., Hosokawa K., Miura H., Yoshikawa K., et al. Regulation of keratin 9 in nonpalmoplantarkeratinocytes by palmoplantar fibroblasts through epithelial-mesenchymal interactions. J Invest Dermatol 112 (1999) 483-488
15. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
16. Lacina L., Smetana Jr. K., Dvořánková B., Pytlík R., Kideryová L., Kučerová L., et al. Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes. Brit J Dermatol 156 (2007) 819-829
17. Lacina L., Dvořánkova B., Smetana Jr. K., Chovanec M., Plzák J., Tachezy R., et al. Marker profiling of normal keratinocytes identifies the stroma from squamous cell carcinoma of the oral cavity as a modulatory microenvironment in co-culture. Int J Radiat Biol 83 (2007) 837-848
18. Rosenberg A.E. Malignant fibrous histiocytoma: past, present, and future. Skeletal Radiol 32 (2003) 613-618
19. Taher A., and Pushpanathan C. Plexiform fibrohistiocytic tumor. Arch Pathol Lab Med 131 (2007) 1135-1137
20. Al-Agha O.M., and Igbokwe A.A. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med 132 (2008) 1030-1035
21. Matoušková E., Veselý P., and Königová R. Modified method of in vitro cultivation of human keratinocytes suitable for grafting. Folia Biol (Praha) 35 (1989) 118-123
22. Grando S.A., Schofield O., Skubitz A.P.N., Kist D.A., Zelickson B.D., Zachary C.B., et al. Nodular basal cell carcinoma in vivo vs in vitro. Arch Dermatol 132 (1996) 1185-1193
23. Gabius H.J., Wosgien B., Hendrys M., and Bardosi A. Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoproteins and lectin-specific antibody. Histochemistry 95 (1991) 269-277
24. Purkrábková T., Smetana Jr. K., Dvořánková B., Holíková Z., Böck C., Lensch M., et al. New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol Cell 95 (2003) 535-545
25. Smetana K.J., Dvořánková B., Chovanec M., Bouček J., Klíma J., Motlík J., et al. Nuclear presence of adhesion/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem Cell Biol 125 (2006) 171-182
26. André S., Kaltner H., Furuike T., Nishimura S.I., and Gabius H.J. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjugate Chem 15 (2004) 87-98
27. Lohr M., Lensch M., André S., Kaltner H., Siebert H.-C., Smetana Jr. K., et al. Murine homodimeric adhesion/growth-regulatory galectins-1, -2 and -7: comparative profiling of gene/promoter sequences by database mining, of expression by RT-PCR/immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol (Praha) 53 (2007) 109-128
28. Siebert H.C., André S., Lu S.Y., Frank M., Kaltner H., van Kuik J.A., et al. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 42 (2003) 14762-14773
29. André S., Pei Z., Siebert H.C., Ramström O., and Gabius H.J. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg Med Chem 14 (2006) 6314-6326
30. Lahm H., André S., Hoeflich A., Kaltner H., Siebert H.-C., Sordat B., et al. Tumor galectinology: insights into the network of a family of endogenous lectins. Glycoconjugate J 20 (2004) 227-238
31. Zelger B., Zelger B.G., and Burgdorf W.H.C. Dermatofibroma-a critical evaluation. Int J Surg Pathol 12 (2004) 333-334
32. Beekman C., Nichane M., De Clercq S., Maetens M., Floss T., Wurst W., et al. Evolutionarily conserved role of nucleostemin: Controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol 26 (2006) 9291-9301
33. De Wever O., Demetter P., Mareel M., and Bradle M. Stromal myofibroblasts are drivers of invasive cancer growthInt. J Cancer 123 (2008) 2229-2238
34. Michel M., Török N., Godbout M.J., Lussier M., Gaudreau P., Royal A., et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially located in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 109 (1996) 1017-1028
35. Habets J.M., Tank B., Vuzevski V.D., Brevé J., Stolz E., van Joost T., et al. Absence of cytokeratin 8 and inconsistent expression of cytokeratin 7 and 19 in human basal cell carcinoma. Anticancer Res 8 (1988) 611-616
36. Dvořánková B., Smetana K.J., Chovanec M., Lacina L., Stork J., Plzáková Z., et al. Transient expression of keratin K19 is induced in originally negative interfollicular epidermal cells by adhesion of suspended cells. Int J Mol Med 16 (2005) 525-531
37. Gires O., Münz M., Schaffrik M., Kieu C., Rauch J., Ahlemann M., et al. Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics based technology. Cell Mol Life Sci 61 (2004) 1198-1207
38. Barcellos-Hoff M.H., and Ravani S.A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60 (2000) 1254-1260
39. Smetana Jr. K., Dvořánková B., Lacina L., Čada Z., and Vonka V. Human hair follicle and interfollicular keratinocyte reactivity to mouse HPV16-transformed cells: an in vitro study. Oncol Rep 20 (2008) 75-80
40. Gabius H.J. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1. Biochimie 83 (2001) 659-666
41. - leukemic T-cells from patients with Sézary syndrome are protected from galectin-1-triggered T-cell death. Leukemia 16 (2002) 840-845
42. André S., Kojima S., Yamazaki N., Fink C., Kaltner H., Kayser K., et al. Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol 125 (1999) 461-474
43. Rotblat B., Niv H., André S., Kaltner H., Gabius H.J., Kloog Y., et al. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res 64 (2004) 3112-3118
44. Villalobo A., Nogales-González A., and Gabius H.J. A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trend Glycosci Glycotechnol 18 (2006) 1-37
45. INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 272 (2007) 3233-3256
46. Saussez S., Decaestecker C., Lorfevre F., Chevalier D., Mortuaire G., Kaltner H., et al. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinoma. Histopathology 52 (2008) 483-493
47. Čada Z., Bouček J., Dvořánková B., Chovanec M., Plzák J., Kodet R., et al. Nucleostemin expression in squamous cell carcinoma of the head and neck. Anticancer Res 27 (2007) 3279-3284
48. Saussez S., Decaestecker C., Cludts S., Ernoux P., Chevalier D., Smetana Jr. K., et al. Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal upregulation in laryngeal carcinomas. Anticancer Res 29 (2009) 59-66
49. Lacina L., Plzáková Z., Smetana Jr. K., Štork J., Kaltner H., André S., et al. Glycophenotype of psoriatic skin. Folia Biol 52 (2006) 10-15